About

McKesson Corporation operates in the healthcare sector, focusing on improving patient care by providing a wide range of products and services. The company works with healthcare providers, pharmacies, and manufacturers to ensure the efficient delivery of medicines and medical products. McKesson acts as a middleman, purchasing medical supplies from manufacturers and distributing them to various healthcare facilities, ensuring that essential items are available when needed. Their revenue comes from selling pharmaceuticals and medical products, as well as offering logistics and supply chain management services. Additionally, McKesson provides technology solutions to help healthcare providers streamline their operations. The company's goal is to facilitate the healthcare supply chain, making sure that critical medical supplies and services reach patients effectively.

Simplify's Take

What believers are saying

• InspiroGene could open new revenue streams in advanced therapies.
• Investments in data-driven healthcare enhance McKesson's service offerings.
• Streamlining operations by selling Rexall and Well.ca may improve efficiency.

What critics are saying

• Closing Rogers center may disrupt local supply chain operations.
• Selling Rexall and Well.ca could reduce market presence in Canada.
• InspiroGene may divert focus from core distribution business.

What makes McKesson unique

• McKesson's InspiroGene focuses on commercializing cell and gene therapies.
• The company invests in real-world evidence generation through Atropos Health.
• McKesson supports rural healthcare access with grants for pharmacist training.

Help us improve and share your feedback! Did you find this helpful?

YesNo